Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents

Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents

© 2018 International Medical Press. Background: Rilpivirine (RPV), a non-nucleoside reverse transcriptase inhibitor drug, could be a favourable drug for maintenance therapy in HIV-infected adolescents because it has few long-term side effects. However, data among adolescents switching from efavirenz...

Saved in:

書目詳細資料
Main Authors:	Watsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Naruporn Kasipong, Narukjaporn Thammajaruk, Jiratchaya Sophonphan, Torsak Bunupuradah, Tim R. Cressey, Angela Colbers, David M. Burger, Wanatpreeya Phongsamart, Thanyawee Puthanakit, Chitsanu Pancharoen
格式:	雜誌
出版:	2018
主題:	Medicine Pharmacology, Toxicology and Pharmaceutics
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85051217524&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/59058
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents
由: Watsamon Jantarabenjakul, et al.
出版: (2019)

Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi-centre 48-week efficacy and safety study in Thailand
由: Wanatpreeya Phongsamart, et al.
出版: (2022)

Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi-centre 48-week efficacy and safety study in Thailand
由: Phongsamart W.
出版: (2023)

Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral Prophylaxis
由: Suvaporn Anugulruengkitt, et al.
出版: (2019)

Nevirapine concentrations during the first month of life and maternal efavirenz washout in high-risk hiv-exposed infants receiving triple antiretroviral prophylaxis
由: Suvaporn Anugulruengkitt, et al.
出版: (2020)

Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants
由: Suvaporn Anugulruengkitt, et al.
出版: (2020)

Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants
由: Suvaporn Anugulruengkitt, et al.
出版: (2020)

Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children
由: Pakpoom Janewongwirot, et al.
出版: (2018)

Safety and effectiveness of switching to abacavir/lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
由: Lim, Z. C., et al.
出版: (2021)

Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
由: Lim, Z. C., et al.
出版: (2022)

Efavirenz pharmacokinetics during pregnancy and infant washout
由: Regis Kreitchmann, et al.
出版: (2019)

Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy
由: Isaac Singini, et al.
出版: (2018)

Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy
由: Singini I., et al.
出版: (2017)

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial
由: Molina J., et al.
出版: (2017)

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial
由: Jean Michel Molina, et al.
出版: (2018)

Adverse events of antiretroviral prophylaxis regimen for elimination and prevention of mother-to-child transmission among HIV-exposed infants
由: Suvaporn Anugulruengkitt
出版: (2018)

Efficacy of rilpivirine-based regimens as switch therapy from nevirapine-based regimens in human immunodeficiency virus-infected patients with virological suppression: A randomized controlled trial
由: Porkaew Petchkum, et al.
出版: (2020)

Neurodevelopmental and Neurobehavioral Outcomes in Early Antiretroviral Treated Young Children with Perinatally-Acquired HIV Infection (PHIV) compared to Age-matched Perinatally HIV-Exposed Uninfected Children (PHEU)
由: Watsamon Jantarabenjakul
出版: (2018)

Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
由: Kulkanya Chokephaibulkit, et al.
出版: (2018)

Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
由: Kulkanya Chokephaibulkit, et al.
出版: (2018)

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women
由: Anna H. Tran, et al.
出版: (2018)

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women
由: Tran A., et al.
出版: (2017)

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children
由: Tim R. Cressey, et al.
出版: (2018)

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children
由: Tim R. Cressey, et al.
出版: (2018)

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children
由: Tim R. Cressey, et al.
出版: (2018)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
由: Tavitiya Sudjaritruk, et al.
出版: (2018)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
由: Tavitiya Sudjaritruk, et al.
出版: (2018)

Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: Pooled results from the phase 3 double-blind randomized ECHO and THRIVE trials
由: Calvin J. Cohen, et al.
出版: (2018)

Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: Pooled results from the phase 3 double-blind randomized ECHO and THRIVE trials
由: Cohen C., et al.
出版: (2017)

Improvement of Mycoepoxydiene production by Endophytic fungus Phomopsis sp. Hants25 isolate from Hydnocarpus anthelminthicus
由: Narukjaporn Thammajaruk
出版: (2009)

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)
由: David A. Wohl, et al.
出版: (2018)

Early and Late Virologic Failure After Virologic Suppression in HIV-Infected Asian Children and Adolescents
由: Weiwei Mu, et al.
出版: (2019)

Early and Late Virologic Failure after Virologic Suppression in HIV-Infected Asian Children and Adolescents
由: Weiwei Mu, et al.
出版: (2020)

Pharmacokinetics of Atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate
由: Torsak Bunupuradah, et al.
出版: (2018)

Hypovitaminosis D and hyperparathyroidism: Effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents
由: Tavitiya Sudjaritruk, et al.
出版: (2018)

Virological and immunological responses of efavirenz-based HAART regimen initiated in HIV-infected patients at CD4 < 100 versus CD4 ≥ 100 cells/mm 3
由: Sasisopin Kiertiburanakul, et al.
出版: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
由: Linda Aurpibul, et al.
出版: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
由: Linda Aurpibul, et al.
出版: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
由: Linda Aurpibul, et al.
出版: (2018)

Etravirine and rilpivirine resistance in HIV-1 subtype CRF01-AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens
由: Torsak Bunupuradah, et al.
出版: (2018)